Table 5.
No of patients |
Effect | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | ACLS/ ALS | No ACLS/ ALS | Relative (95% CI) | Certainty | Importance |
ROSC | |||||||||||
7 | Observational studies | seriousa | seriousb | seriousc | seriousd | none | 480/ 1211 (39.6%) | 261/ 882 (29.6%) | OR 1.66 (1.24 to 2.21) | CRITICAL | |
Survival to discharge and 30 days | |||||||||||
8 | Observational studies | seriousa | seriousb | seriousc | seriousd | none | 309/ 995 (31.1%) | 111/ 672 (16.5%) | OR 2.48 (1.21 to 5.09) | CRITICAL | |
1 year survival | |||||||||||
2 | Observational studies | seriousa | seriousb | seriousc | seriousd | none | 51/ 262 (19.5%) | 31/ 193 (16.1%) | OR 3.61 (0.11 to 119.42) | CRITICAL |
Mixture of serious and low risk of bias studies.
Some studies showed significant improvement, and some showed no improvement.
Differences in patient type, hospital type, provider type and team composition, and nature of intervention.
Absence of confidence intervals.